ABSTRACT
INTRODUCTION
A primary role in regulating the activity of the basal transcriptional machinery is exerted by promoter-specific transcription factors (TFs) (1) . In order to adjust the expression of target genes according to external requirements, signaling mechanisms control molecular functions of TFs. The activity of a TF can be regulated at different levels: (i) at the mRNA production level through changes in the activity of its transcription unit (2,3); (ii) at the pre-translational level through alternative splicing (4, 5) ; (iii) at the post-translational level through modifications of the glycosylation (6), acetylation (7), phosphorylation (8) and redox state (9) of the TF itself. Since it acts on pre-existing molecules, regulation at the redox state level represents a fast and cheap way to regulate TF activity and, in recent years, it has been well documented (10) . Redox regulation chiefly occurs through reduction/oxidation of specific cysteine residues that are situated in the DNA-binding domains of TFs. Examples of regulation of TFs by redox of reactive cysteine residues in eukaryotes are those of AP-1 and NF-κB (11; for a review see 12) . Both proteins require reducing conditions for DNA binding in vitro, while in vivo these factors become activated by oxidative stress-promoting agents such as H 2 O 2 and bleomycin (12) . This apparent contradiction has been explained by the finding of the presence of reducing enzymes, such as thioredoxin (TRX) and Ref-1, whose expression is induced by oxidative stress (13, 14) .
Ref-1 has been identified as a protein capable of either apurinic/apyrimidinic endonuclease DNA repair activity and nuclear redox activity, being able to induce AP-1 DNAbinding activity, as well as that of NF-κB, Myb, members of the ATF/CREB family, HIF-1α (14) and p53 (15) . Ref-1 protein expression is selectively induced by non-toxic levels of a variety of reactive oxygen species (ROS), such as the superoxide anion ( ), H 2 O 2 and the hydroxyl radical ( · OH), which are by-products of respiration. ROS can also be generated by external agents, such as ionizing radiation (16) , during pathological states in activated neutrophils and as a useful tuning device for intracellular signal transduction, as is the case of the *To whom correspondence should be addressed. Tel: +39 0432 494340; Fax: +39 0432 494301; Email: cpucillo@makek.dstb.uniud.it O 2
• cascades induced by cytokines such as tumor necrosis factor-α or interleukin-1β (11 (18) . From a regulatory point of view this is an apparent paradox, since the external signal would use a fast mechanism of regulation (i.e. reduction of cysteine residues) via a timeconsuming event such as new synthesis of the regulator (i.e. . For this reason we explored the possibility that Ref-1 function is controlled at a different level than synthesis by using the lymphocyte/BSAP model. Lymphocytes are one of the cell types which are subjected to oxidative stress during the inflammatory response and which use ROS as a tuning device for signal transduction (10) . BSAP plays a key role in regulating fundamental events in B cells, such as differentiation and isotype switching, which occur during the inflammatory response in particular areas called germinal centers. BSAP (also called Pax-5, therefore here referred to as BSAP/Pax-5) belongs to the Pax family of TFs, which play a developmental role in a wide variety of species from nematodes to vertebrates (19) . Pax proteins recognize DNA sequences through a conserved element called the Prd domain. We have recently demonstrated that the DNA-binding activity of the Prd domain (20) is redox sensitive and that the transcriptional activity of Pax-8 is directly regulated by .
We here demonstrate that the first event of Ref-1 regulation consists of an increase in cytoplasmic to nuclear translocation. By this mechanism BSAP/Pax-5 is activated and, therefore, an outside/inside signaling pathway is generated in B cells.
MATERIALS AND METHODS

Expression vectors
Plasmid pDS56Ref-1 was used for expression of recombinant Ref-1 His-tagged protein, while for eukaryotic expression we used the vector CMV-Ref-1 (22) . Plasmid pT7.7Pax-5 was used for recombinant BSAP/Pax-5 protein expression (20, 23) . For eukaryotic expression of BSAP/Pax-5, we used the vector CMV-BSAP together with a ∆71-BSAP promoter construct, which bears two copies of the CD19 BSAP site in the SalI site of ∆71 upstream of a chloramphenicol acetyltransferase (CAT) reporter gene.
Protein expression and purification
The recombinant Pax-5 protein (rPax-5) was obtained from overexpression in Escherichia coli and then purified to homogeneity by ion exchange chromatography onto a Mono-S column (Pharmacia) following previous published procedures (20) . The purified protein gave a single band on an overloaded SDS-PAGE gel. Fractions containing purified proteins were dialyzed against water and then stored at -85°C. When required, in vitro protein oxidation was obtained by prolonged air exposure.
The recombinant Ref-1 protein (rRef-1) was obtained as an hexahistidine tag fusion protein by overexpression in E.coli and then purified by nickel chelate chromatography from bacterial extracts and treated as previously described (22) . The protein was dialyzed against a reducing buffer containing 5 mM DTT. For the functional assay the protein was then diluted 1:100 in non-DTT containing buffer.
Proteins concentrations were determined using the Bradford method (24) .
EMSA analysis
Double-stranded oligodeoxynucleotides, labeled at the 5′-end with 32 P, were used as probes in gel retardation assays. The H2A-2.2 site is a 25mer whose upper strand is 5′-TCTGACG-CAGCGGTGGGTGACGACT-3′ (25) . The BS2 site is an 18mer whose upper strand is 5′-CTCTAATGGCTTTTTCTC-3′ (20) . The EMSA was performed as previously described (20) . The gel was dried and then exposed to an X-ray film at -80°C.
Cell lines and transfection
Raji cells were grown in RPMI 1640 medium while HeLa and NS-1 cells were grown in Dulbecco's modified Eagle's medium (DMEM). Both media were supplemented with 10% fetal calf serum (FCS), glutamine and antibiotics.
HeLa cells (0.8 × 10 6 cells/60 mm culture dish) were transfected using a calcium phosphate method (26) . NS-1 cells were transfected by electroporation using a Bio-Rad gene pulser (Bio-Rad Inc.). Aliquots of 1.5 × 10 7 cells were resuspended in 350 µl of RPMI in a Bio-Rad electroporation cuvette (0.4 cm gap) and pulsed once with 340 V and 960 µF. After electroporation, cells were maintained at 4°C for 10 min and then cultured in pre-equilibrated RPMI supplemented with 10% fetal serum for 24 h. The following amounts of plasmids were transfected where needed: CMV-Ref-1, 5 µg; CMV-Luc, 5 µg; ∆71-BSAP, 7.5 µg; CMV-BSAP, 7.5 µg. CAT (27) and Luc (28) activities were measured as described in the cited references.
The protein levels achieved in all transfection experiments were comparable and were monitored by western blot analysis using specific antibodies raised against BSAP/Pax-5 and Ref-1, respectively. Moreover, the levels of transactivation were calculated as the CAT/Luc ratios, the luciferase gene activity being the normalizer.
Preparation of nuclear extracts and western blot analysis
Cell nuclear extracts were prepared as previously described (20) . The nuclear extracts were then quantitated for protein levels according to the Bradford method (24) and used immediately for western blot or EMSA analysis or kept at -80°C.
For western blot analysis, 10 µg of nuclear extracts were electrophoresed on a 12% SDS-PAGE minigel and transferred to nitrocellulose membrane (Schleicher & Schuell, Keene, NH) as previously described (20, 29) . The blots were developed using the ECL chemiluminescence method (Amersham Pharmacia Biotech) using Biomax-Light films (Kodak) and bands were quantitated by densitometric scanning of the autoradiograms using an LKB densitometer. All data were confirmed by Gel Doc 2000 analysis (Bio-Rad Inc.).
Immunofluorescence and confocal laser scanning microscopy
Suspension cultures of Raji cells, untreated (control) or treated with 50 µM H 2 O 2 for the indicated times, were centrifuged onto ethanol-cleaned slides. Cytospins were air dried and fixed with 3.7% formaldehyde in PBS for 10 min at room temperature. After washing with 0.1% BSA/PBS, cells were permeabilized with 0.1% Triton X-100 in 0.1% BSA/PBS and 4% FCS for 1 min at room temperature. The slides were extensively washed with 0.1% BSA/PBS and blocked for 30 min with 2% BSA/PBS prior to application of antibodies. Incubation with both primary rabbit polyclonal anti-Ref-1 (29) and secondary (FITC-labeled anti-rabbit IgG; Diagnostics Pasteur, MarnesLa-Coquette, France) antibodies, diluted in 0.1% BSA/PBS (1:100), was for 1 h at room temperature in a moist chamber. Nuclei were counterstained with 80 nM ethidium homodimer-1 (EthD-1) (Molecular Probes Inc., Eugene, OR). The slides were then mounted in Mowiol (Calbiochem, La Jolla, CA) containing 2.5% (w/v) 1,4-diazabicyclo[2,2,2]octane (DABCO) (Sigma Chemical Co., St Louis, MO) as antifading agent.
Immunofluorescence-labeled cell preparations were studied using a Bio-Rad MRC 1024 confocal laser scanning microscope (Bio-Rad Inc.) equipped with an argon laser attached to a Nikon Diaphot inverted microscope with a 60× oil immersion objective lens of numerical aperture 1.4. The excitation wavelengths used were 488 (FITC) and 568 nm (EthD-1). Filters used for collecting emission signals were 522/35 (FITC) and 605/32 nm (EthD-1). For acquisition the same conditions were used. For two color fluorescence the red and green signals were collected simultaneously. To create a two color image, the red and green images were merged. Co-localization appears as yellow because of the mixture of red and green.
Metabolic labeling and immunoprecipitation
Metabolic pulse labeling was performed as previously described (30) . After chasing, cells were treated with 50 µM H 2 O 2 and collected at the indicated times for immunoprecipitation of the endogenous Ref-1 protein from nuclear extracts. Nuclear extracts were incubated for 2 h at 4°C with gentle tumbling with 20 µl of total rabbit IgG linked to CNBr-activated Sepharose 4B beads (Amersham Pharmacia Biotech). The pre-cleared samples were then centrifuged and incubated, overnight at 4°C and with gentle tumbling, with 25 µl of polyclonal anti-Ref-1 antibody (29) linked to CNBr-activated Sepharose 4B beads at a final concentration of 50 µg antibody/ml resin. After incubation, the immunoprecipitated material was washed sequentially with 100 µl 1% Nonidet P-40 (Pierce), 100 µl 1% Triton X-100 (Pierce) and 100 µl 1% SDS. Elution was carried out with 50 µl of 2× Laemmli sample buffer. The eluted proteins were run on a 12% denaturing SDS-polyacrylamide reducing gel. Gels containing [ 35 S]methionine-labeled material were processed for autoradiography. After fixation for 20 min with 10% acetic acid and 10% methanol, the gel was enhanced with an enlightening solution (NEN Life Science Products), dried and exposed to film (Kodak X-Omat AR) at -80°C for 3-5 days. (Fig. 1B, filled triangles) but not the Ref-1 increase in the nucleus (Fig. 1C, filled diamonds) . In fact, at 3 h, the increase in Ref-1 levels in the nuclear fraction was largely independent of de novo protein synthesis (Fig. 1C, filled  diamonds, see arrow) . At later times, 6-9 h, the nuclear increase was greatly, if not completely, due to de novo synthesis of protein, while at 12 h there was a decrease in total protein (Fig. 1C, open diamonds) . Therefore, an early event occurring soon after H 2 O 2 treatment was accelerated translocation of Ref-1 from the cytoplasmic compartment to the nucleus. Supportive evidence for this phenomenon was provided by a pulse-chase experiment. [ 35 S]methionine-labeled Raji cells were pulsed overnight, maintained in chase medium for 1 h and then treated with 50 µM H 2 O 2 for different lengths of time (3, 6 and 9 h). Nuclear extracts were immunoprecipitated with an anti-Ref-1 antibody and it was found that the ratio of Ref-1 levels in treated versus non-treated cells was higher at 3 h (ratio~3.5) and progressively decreased at 6 (ratio~2) and 9 h (ratio~1) (Fig. 2) .
RESULTS
The initial event in activation of Ref-1 is its translocation into the nucleus
To further investigate nuclear translocation at early times after H 2 O 2 treatment the subcellular distribution of Ref-1 was determined by two color analysis and confocal microscopy (Fig. 3) . In untreated cells (Fig. 3a) Ref-1 was detected mostly in the cytoplasm (green signal) and not in the nucleus, which is stained red by EthD-1. Treatment with H 2 O 2 induced a visible Ref-1 mobilization towards the nucleus, as could be seen by the considerable increase in yellow staining indicative of colocalization at the periphery of the nucleus after 30 and 120 min of treatment (Fig. 3b and c, respectively) . At these early times there was little evidence of de novo protein synthesis, since the 'green' signal decreased consistently in the cell cytoplasm. The signal for both cytoplasmic and nuclear localization of Ref-1 became much more intense after a 6 h treatment (Fig. 3d) . These data show that Ref 4A, lanes 2 and 3) . This increase in BSAP/ Pax-5 DNA-binding activity was not due to an increase in the protein levels since they were not influenced by H 2 O 2 treatment (Fig. 4B) (Fig. 5, lane 3) . Instead, a strong reducing environment (5 mM DTT) was necessary to demonstrate DNA-binding activity (lane 2). The addition of reduced rRef-1 protein (final concentration 0.05 mM DTT) resulted in rPax-5 DNA-binding activity (Fig. 5, lanes 7 and 8) . The oxidized form of rRef-1 was totally ineffective (data not shown). In addition, it is evident that the interaction between rPax-5 and rRef-1 is likely to be of a transient nature because there was no change in mobility of rPax-5-DNA complexes when comparing the samples stimulated with DTT (Fig. 5 , lane 2) and those stimulated with Ref-1 (Fig. 5, lanes 7 and 8) .
Ref-1 increases Pax-5 transcriptional activity
The ∆71-BSAP promoter is not functional when transfected into HeLa cells, but its activity can be reconstituted by forced expression of BSAP/Pax-5 due to the presence of polymerized BSAP/Pax-5 binding sites in the CD19 promoter (32) . Nuclear extracts (lanes 2-3) were prepared as described in Materials and Methods. An aliquot of 5 µg of protein was reacted with a 32 P-labeled H2A-2.2 probe (25). Samples were analyzed on a native 7% polyacrylamide gel. An autoradiograph of the gel is shown. The arrow indicates the position of the BSAP/Pax-5-DNA specific complex. To test for the specificity of the complex, a competition assay with cold specific and non-specific oligonucleotide was performed. As expected, the specific H2A-2.2 oligonucleotide efficiently reduces the BSAP/Pax-5-DNA complex (lanes 4 and 5), whereas the non-specific BS2 oligonucleotide is almost ineffective (lanes 6 and 7) . 
DISCUSSION
ROS are harmful by-products of oxidative metabolism but are also used in eukaryotic cells as second messengers in signal transduction pathways from cytokine-receptor interactions to activation of TF (10) . In fact, it has been shown that IL-1β induces NF-κB activation through the production of ROS in lymphoid cells (34) and this activity is regulated through oxidation/reduction of cysteine residues in critical positions (35) . Redox regulation of TF activation mostly occurs in the nuclear compartment and, in turn, requires a system of regulation. The nuclear protein Ref-1 is a clear candidate for the role of shuttle factor between the cytoplasm and the nucleus, being able to modify, after stimulation, the nuclear redox potential of the cell. Therefore, Ref-1 seems to fit with previous requirements. In fact: (i) it is able to stimulate the DNA-binding activity of TFs AP-1, NF-κB, Myb and p53 (14, 15) ; (ii) it is an inducible enzyme, whose expression is up-regulated when cells are exposed to oxidative stresses (36) (37) (38) ; (iii) its expression level is chronologically strictly controlled and another redox enzyme (TRX) is a cytoplasmatic partner which seems to be involved in extracellular to nuclear environment signaling (39) . We have recently demonstrated that the structure and in vitro binding activity of the Prd domain of Pax proteins is regulated through the oxidation/reduction of conserved cysteine residues To our knowledge, Ref-1 expression levels have never previously been investigated in a lymphoid cell system. In fact, all studies have concerned its expression in epithelial cells (skin, thyroid, liver and duodenum) (29, 40) , in the central nervous system (brain, hippocampus and cerebellum) (29, 41) activity of BSAP/Pax-5 by increasing the reduced form of this TF in the nucleus. Therefore, our model could represent a chronologically and energetically more economical means of regulating BSAP/Pax-5 activity.
Several experimental approaches have consistently suggested that BSAP/Pax-5 regulates distinct classes of genes during B cell differentiation, acting either as a positive or negative regulator of gene expression (2, 44) . This double nature of BSAP/Pax-5 (as positive or negative regulator of gene expression) includes, in the same TF, the possibility of accurately regulating B cell functions and suggests that this TF plays a fundamental role in activation and proliferation. Thus, mechanisms able to control the activity of BSAP/Pax-5 will enable B cell differentiation and activation. A good model to test this could be the mechanism of isotype switching in B cells. Since transcription of the Ref-1 gene is itself regulated, requiring elements such as a multiprotein complex containing c-jun, and is modulated by means of second messengers such as cAMP (17) , it is possible to speculate that stimuli other than ROS could modulate the transcriptional activity of TFs activated by Ref-1. PGE 2 is known to promote B lymphocyte Ig class switching from IgA to IgE through a mechanism which up-regulates intracellular cAMP levels (45) . It is remarkable that the same result is produced by overexpressing BSAP/Pax-5 in the I.29µ murine B cell line (46) , which inhibits switching to IgA and enhances switching to IgE. Therefore, it could be hypothesized that Ref-1 could play a role in mediating BSAP/ Pax-5-regulated IgE class switching following PGE 2 treatment of B cells. The switch between repression and activation of BSAP/Pax-5-regulated gene expression might be through modulation of BSAP/Pax-5 protein levels by synthesis or degradation. However, a change in nuclear levels of BSAP/ Pax-5 through de novo synthesis of protein is time and energy consuming. Moreover, exposure to cytokines and chemical stimuli requires rapid modification of the transcription apparatus. This can only happen if control of TF activity is dependent on a fast 'shuttle factor' that transduces, at the nuclear level, signals generated in the cytoplasm by intra-or extracellular signal pathways.
